These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10969635)
1. Electrophysiological effects of blocking and stimulating the opioid system in patients with unexplained heart palpitations. Oldroyd KG Clin Cardiol; 1992 Nov; 15(11):872-3. PubMed ID: 10969635 [No Abstract] [Full Text] [Related]
3. Electrophysiologic effects of blocking and stimulating the opioid system in patients with unexplained heart palpitations. Markiewicz K; Kuś W; Cholewa M; Bubiński R Clin Cardiol; 1991 Oct; 14(10):813-20. PubMed ID: 1659505 [TBL] [Abstract][Full Text] [Related]
4. Opioid receptor mediated anticonvulsant effect of pentazocine. Khanna N; Khosla R; Kohli J Indian J Med Sci; 1998 Jan; 52(1):1-7. PubMed ID: 9770858 [TBL] [Abstract][Full Text] [Related]
5. Naloxone in treating central adverse effects during opioid titration for cancer pain. Mercadante S; Villari P; Ferrera P J Pain Symptom Manage; 2003 Aug; 26(2):691-3. PubMed ID: 12906952 [No Abstract] [Full Text] [Related]
6. [Narcotic analgesics. Part IV. Agonists-antagonists and total antagonists of opiate receptors. Perspectives for clinical use of narcotic analgesics]. Dubitskiĭ AE; Beliaev AV; Ryzhiĭ SM; Volikovskaia EV; Butylin VIu; Davydov NIu Klin Khir (1962); 1993; (7-8):64-8. PubMed ID: 7511186 [No Abstract] [Full Text] [Related]
7. Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model. Wolfes J; Ellermann C; Burde S; Leitz P; Bögeholz N; Willy K; Fehr M; Reinke F; Eckardt L; Frommeyer G Cardiovasc Toxicol; 2021 Mar; 21(3):248-254. PubMed ID: 33125619 [TBL] [Abstract][Full Text] [Related]
8. Optimal dose range of epidural naloxone to reduce nausea in patients receiving epidural morphine. Kim ES; Lee J; Choi JH Can J Anaesth; 2004 Dec; 51(10):1048-9. PubMed ID: 15574562 [No Abstract] [Full Text] [Related]
9. Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence. van Niel JC; Schneider J; Tzschentke TM Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867 [TBL] [Abstract][Full Text] [Related]
10. Using mixed agonist-antagonists. D'Arcy Y Nursing; 2005 Feb; 35(2):17. PubMed ID: 15706252 [No Abstract] [Full Text] [Related]
11. Ventricular tachycardia following naloxone administration in an illicit drug misuse. Hunter R J Clin Forensic Med; 2005 Aug; 12(4):218-9. PubMed ID: 16054011 [TBL] [Abstract][Full Text] [Related]
12. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence. Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113 [No Abstract] [Full Text] [Related]
13. A naloxone admixture to prevent opioid-induced pruritus in children: a randomized controlled trial. West N; Ansermino JM; Carr RR; Leung K; Zhou G; Lauder GR Can J Anaesth; 2015 Aug; 62(8):891-900. PubMed ID: 25902891 [TBL] [Abstract][Full Text] [Related]
14. [Treament of morphine-induced constipation with oral naloxone]. Latasch L; Zimmermann M; Eberhardt B; Jurna I Anaesthesist; 1997 Mar; 46(3):191-4. PubMed ID: 9163262 [TBL] [Abstract][Full Text] [Related]